KHA Releases One-Pager Supporting SB 27

Share

Protect Private Money Providing Patient Access

The 340B drug discount program is a privately funded, federally administered system. The program allows non-profit, safety-net hospitals to purchase outpatient medications from pharmaceutical manufacturers at the same price the manufacturers charge their best customers – NOT for free.

Pharmaceutical manufacturers, which continue to have record profits, agreed to fund the 340B program in order to be a part of Obamacare. Now they want to back out of that commitment. Their refusal to ship prescription drugs comes at the expense of the poorest and most vulnerable patients being served by 340B hospitals.

The savings from the program help Kentucky hospitals to maintain access to care and make it possible for hospitals to offer additional services to their patients.

Latest News

News
April 30, 2025
Learn how you can be involved in the development of an action plan to help identify gaps which prevent people with diabetes from being regularly screened for kidney & eye disease.
Convention
April 29, 2025
Book your hotel room now!
News
April 29, 2025
The Centers for Medicare and Medicaid Services (CMS) recently issued a new version of the Medicare Advantage Provider Complaint Submission Form.